| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca5e90b147553aa5db872967761c7d37 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577 |
| filingDate |
1999-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbf3be51b620b343f85fe9c66759d7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2b4049e25890eae363ab000376c1bac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_188077ec1d74fd832ddd6d3ed581a9f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6440476c457fe2aff0cc186bf5f0a6f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0f5af90509a741a2577310c9abf23f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60a702712fc5bcab1b9f4300c000888f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_974a89774a6aa3b2e06346ad45e35296 |
| publicationDate |
2001-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1085088-A1 |
| titleOfInvention |
Monoclonal antibodies and method for assaying fdp |
| abstract |
The present invention provides two kinds of monoclonalnantibodies which do not react with specific fractions in humannfibrin/fibrinogen degradation products by plasmin andndiscloses a method of measuring FDP by using plasma as a specimennusing the two kinds of the monoclonal antibodies according tonthe immunological agglutination method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2599865-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103025871-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104198724-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865425-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103026231-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865424-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104198724-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103025871-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103026231-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103954758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2599865-A1 |
| priorityDate |
1998-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |